# Ciclosporin to Reduce Reperfusion Injury in Primary PCI

> **NCT02390674** · PHASE2 · COMPLETED · sponsor: **Newcastle-upon-Tyne Hospitals NHS Trust** · enrollment: 54 (actual)

## Conditions studied

- Myocardial Reperfusion Injury

## Interventions

- **DRUG:** Ciclosporin
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT02390674
- **Lead sponsor:** Newcastle-upon-Tyne Hospitals NHS Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2017-04
- **Final completion:** 2017-11-11
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2018-03-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02390674

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02390674, "Ciclosporin to Reduce Reperfusion Injury in Primary PCI". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02390674. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*